Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros












Base de datos
Tipo de estudio
Intervalo de año de publicación
1.
MMWR Morb Mortal Wkly Rep ; 71(38): 1220-1221, 2022 Sep 23.
Artículo en Inglés | MEDLINE | ID: mdl-36136958

RESUMEN

In August 2022, the Florida Department of Health (FDOH) was notified of a suspected case of monkeypox in an infant aged <2 months who was admitted to a Florida hospital with a rash and cellulitis. This case report highlights findings from the related epidemiologic investigation and describes the public health actions taken. This activity was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy.* This is the youngest patient with confirmed monkeypox infection in Florida to date.


Asunto(s)
Exantema , Mpox , Florida/epidemiología , Humanos , Lactante , Salud Pública
2.
Am J Physiol Renal Physiol ; 307(5): F560-70, 2014 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-24920756

RESUMEN

Nearly all patients with tuberous sclerosis complex (TSC) develop renal angiomyolipomas, although the tumor cell of origin is unknown. We observed decreased renal angiomyolipoma development in patients with TSC2- polycystic kidney disease 1 deletion syndrome and hypertension that were treated from an early age with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers compared with patients who did not receive this therapy. TSC-associated renal angiomyolipomas expressed ANG II type 1 receptors, platelet-derived growth factor receptor-ß, desmin, α-smooth muscle actin, and VEGF receptor 2 but did not express the adipocyte marker S100 or the endothelial marker CD31. Sera of TSC patients exhibited increased vascular mural cell-secreted peptides, such as VEGF-A, VEGF-D, soluble VEGF receptor 2, and collagen type IV. These findings suggest that angiomyolipomas may arise from renal pericytes. ANG II treatment of angiomyolipoma cells in vitro resulted in an exaggerated intracellular Ca(2+) response and increased proliferation, which were blocked by the ANG II type 2 receptor antagonist valsartan. Blockade of ANG II signaling may have preventative therapeutic potential for angiomyolipomas.


Asunto(s)
Angiomiolipoma/tratamiento farmacológico , Angiomiolipoma/patología , Antagonistas de Receptores de Angiotensina/uso terapéutico , Neoplasias Renales/tratamiento farmacológico , Neoplasias Renales/patología , Pericitos/patología , Esclerosis Tuberosa/complicaciones , Angiomiolipoma/fisiopatología , Angiotensina II/fisiología , Antagonistas de Receptores de Angiotensina/farmacología , Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico , Calcio/metabolismo , Línea Celular Tumoral , Proliferación Celular/fisiología , Humanos , Técnicas In Vitro , Riñón/efectos de los fármacos , Riñón/metabolismo , Riñón/patología , Neoplasias Renales/fisiopatología , Receptor de Angiotensina Tipo 1/fisiología , Sistema Renina-Angiotensina/fisiología , Transducción de Señal/fisiología , Tetrazoles/farmacología , Tetrazoles/uso terapéutico , Esclerosis Tuberosa/patología , Esclerosis Tuberosa/fisiopatología , Valina/análogos & derivados , Valina/farmacología , Valina/uso terapéutico , Valsartán
3.
J Am Soc Nephrol ; 25(6): 1187-97, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24511141

RESUMEN

Domoic acid (DA), an excitatory amino acid produced by diatoms belonging to the genus Pseudo-nitzschia, is a glutamate analog responsible for the neurologic condition referred to as amnesic shellfish poisoning. To date, the renal effects of DA have been underappreciated, although renal filtration is the primary route of systemic elimination and the kidney expresses ionotropic glutamate receptors. To characterize the renal effects of DA, we administered either a neurotoxic dose of DA or doses below the recognized limit of toxicity to adult Sv128/Black Swiss mice. DA preferentially accumulated in the kidney and elicited marked renal vascular and tubular damage consistent with acute tubular necrosis, apoptosis, and renal tubular cell desquamation, with toxic vacuolization and mitochondrial swelling as hallmarks of the cellular damage. Doses≥0.1 mg/kg DA elevated the renal injury biomarkers kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin, and doses≥0.005 mg/kg induced the early response genes c-fos and junb. Coadministration of DA with the broad spectrum excitatory amino acid antagonist kynurenic acid inhibited induction of c-fos, junb, and neutrophil gelatinase-associated lipocalin. These findings suggest that the kidney may be susceptible to excitotoxic agonists, and renal effects should be considered when examining glutamate receptor activation. Additionally, these results indicate that DA is a potent nephrotoxicant, and potential renal toxicity may require consideration when determining safe levels for human exposure.


Asunto(s)
Ácido Kaínico/análogos & derivados , Toxinas Marinas/toxicidad , Fármacos Neuromusculares Despolarizantes/toxicidad , Unión Neuromuscular/efectos de los fármacos , Animales , Relación Dosis-Respuesta a Droga , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Hipocampo/patología , Ácido Kaínico/farmacocinética , Ácido Kaínico/toxicidad , Riñón/efectos de los fármacos , Riñón/metabolismo , Riñón/patología , Hígado/efectos de los fármacos , Hígado/metabolismo , Hígado/patología , Toxinas Marinas/farmacocinética , Ratones Endogámicos , Microscopía Electrónica de Transmisión , Dilatación Mitocondrial/efectos de los fármacos , Miocardio/metabolismo , Miocardio/patología , Fármacos Neuromusculares Despolarizantes/farmacocinética , Unión Neuromuscular/metabolismo , Proteínas Proto-Oncogénicas c-fos/genética , Proteínas Proto-Oncogénicas c-fos/metabolismo , Receptores de Ácido Kaínico/genética , Receptores de Ácido Kaínico/metabolismo , Factores de Transcripción/genética , Factores de Transcripción/metabolismo , Vacuolas/patología , Vacuolas/ultraestructura , Receptor de Ácido Kaínico GluK2
4.
IEEE Trans Vis Comput Graph ; 13(6): 1208-15, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17968066

RESUMEN

Documents and other categorical valued time series are often characterized by the frequencies of short range sequential patterns such as n-grams. This representation converts sequential data of varying lengths to high dimensional histogram vectors which are easily modeled by standard statistical models. Unfortunately, the histogram representation ignores most of the medium and long range sequential dependencies making it unsuitable for visualizing sequential data. We present a novel framework for sequential visualization of discrete categorical time series based on the idea of local statistical modeling. The framework embeds categorical time series as smooth curves in the multinomial simplex summarizing the progression of sequential trends. We discuss several visualization techniques based on the above framework and demonstrate their usefulness for document visualization.


Asunto(s)
Algoritmos , Gráficos por Computador , Sistemas de Administración de Bases de Datos , Bases de Datos Factuales , Documentación/métodos , Almacenamiento y Recuperación de la Información/métodos , Interfaz Usuario-Computador , Inteligencia Artificial , Reconocimiento de Normas Patrones Automatizadas/métodos
5.
J Steroid Biochem Mol Biol ; 98(4-5): 218-27, 2006 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-16466914

RESUMEN

Previously, we have shown that progestins both stimulate proliferation of the progesterone receptor (PR)-rich human breast cancer cell line T47D and protect from cell death, in charcoal-stripped serum-containing medium. To lessen the variability inherent in different preparations of serum, we decided to further characterize progestin inhibition of cell death using serum starvation to kill the cells, and find that progestins protect from serum-starvation-induced apoptosis in T47D cells. This effect exhibits specificity for progestins and is inhibited by the antiprogestin RU486. While progestin inhibits cell death in a dose-responsive manner at physiological concentrations, estradiol-17beta surprisingly does not inhibit cell death at any concentration from 0.001 nM to 1 microM. Progestin inhibition of cell death also occurs in at least two other human breast cancer cell lines, one with an intermediate level of PR, MCF-7 cells, and, surprisingly, one with no detectable level of PR, MDA-MB-231 cells. Further, we have found progestin inhibition of cell death caused by the breast cancer chemotherapeutic agents doxorubicin and 5-fluorouracil. These data are consistent with the building body of evidence that progestins are not the benign hormones for breast cancer they have been so long thought to be, but may be harmful both for undiagnosed cases and those undergoing treatment.


Asunto(s)
Apoptosis/efectos de los fármacos , Neoplasias de la Mama/tratamiento farmacológico , Progestinas/farmacología , Antibióticos Antineoplásicos/farmacología , Antimetabolitos Antineoplásicos/farmacología , Neoplasias de la Mama/metabolismo , Neoplasias de la Mama/patología , Doxorrubicina/farmacología , Estradiol/farmacología , Femenino , Fluorouracilo/farmacología , Humanos , Receptores de Progesterona/metabolismo , Células Tumorales Cultivadas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...